Company Overview of UCB Pharma GmbH
UCB Pharma GmbH develops, commercializes, and markets pharmaceutical and biotechnological products. It develops novel medicines in the therapeutic areas of the central nervous system. The company was formerly known as Schwartz Pharma AG and changed its name to UCB Pharma GmbH in May 2009. UCB Pharma GmbH was founded in 1946 and is based in Monheim, Germany. UCB Pharma GmbH operates as a subsidiary of UCB S.A.
Founded in 1946
49 2173 48 4848
49 2173 48 4841
Key Executives for UCB Pharma GmbH
Similar Private Companies By Industry
|3B Pharmaceuticals GmbH||Europe|
|Accelsiors Group International||Europe|
|Aenova Group GmbH||Europe|
|Aenova Holding GmbH||Europe|
|AiCuris GmbH & Co. KG||Europe|
Recent Private Companies Transactions
August 4, 2016
|International Medication Systems (UK) Limited|
February 1, 2016
|UCB Pharma GmbH, Three Cardiovascular Products|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact UCB Pharma GmbH, please visit www.ucb.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.